Missing/wrong data?
Log in to edit
The use of O-(2-18F-fluoroethyl)-L-tyrosine PET for treatment management of bevacizumab and irinotecan in patients with recurrent high-grade glioma: a cost-effectiveness analysis
scientific article published on 19 June 2013
Author/s
author: Karl-Josef Langen, Norbert Galldiks, Felix M Mottaghy, Alexander Heinzel
Work details
Publication date
June 19, 2013
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.